// App-Quantinova.ai

e15635 : Identification of potentially actionable molecular alterations in advanced hepatocellular carcinoma (HCC).

Researchers

Presenter

  • James J. Harding

Principal Investigators

  • Louise Catherine Connell

  • Tara Soumerai

  • Nancy E. Kemeny

  • William R. Jarnagin

  • Eileen Mary O'Reilly

  • Ronald P. DeMatteo

  • Michael Ian D'Angelica

  • Maeve Aine Lowery

  • T. Peter Kingham

  • Maya Gambarin

  • David Michael Hyman

  • Michele LY

  • Casey R. Hamilton

  • Michael F. Berger

  • David B. Solit

  • Leonard Saltz

  • Nikolaus Schultz

  • Ghassan K. Abou-Alfa

Medical Centers

  • Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved